Market Cap
199424114688.00
NVS
Novartis AG
Exchange: nyse
Multiples
- P/E: 17.40
- P/BV: 4.60
- P/TBV: 8.52
Description:
NVS is the ticker symbol for Novavax Inc., a biotechnology company listed on the NYSE. Novavax is a leading developer of innovative vaccines and therapies against infectious diseases. The company has made significant strides in the development of its COVID-19 vaccine, NVX-CoV2373, and has partnered with various governments and organizations to ensure global access to the vaccine. As a result, NVS stock has experienced significant fluctuations in recent years, driven by the company's progress in vaccine development and its response to the pandemic.
Data:
Yields:
Earnings Yield
1.146220173771
Return on Capital
0.420204237350
CAGR (net income)
23.12%
CAGR Length
3.75
Dividend Rate
3.740000
